Sequential changes in CGRP-like immunoreactivity in NIDDM Model Otsuka long-evans Tokushima fatty (OLETF) rat pancreatic islets

Pancreas

Volumn 17, Issue 1, 1998, Pages 72-79

  Manaka, Yukiko ^a   Watanabe, Michiko ^a   Yamaguchi, Koichi ^a   Manaka, Hideo ^a   Kato, Takeo ^a   Yamatani, Keiichi ^a   Tominaga, Makoto ^a   Sasaki, Hideo ^a  

^a YAMAGATA UNIVERSITY   (Japan)

Author keywords

Calcitonin gene related peptide; Non insulin dependent diabetes mellitus; Otsuka Long Evans Tokushima Fatty rats

Indexed keywords

CALCITONIN GENE RELATED PEPTIDE; GLUCOSE; INSULIN; SOMATOSTATIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; IMMUNOREACTIVITY; INSULIN BLOOD LEVEL; INSULIN RELEASE; MALE; NERVE FIBER; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; RAT;

EID: 0031844784     PISSN: 08853177     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006676-199807000-00009     Document Type: Article

References (23)

1. Amara SG, Jonas V, Rosenfed MG, Ong ES, Evans RM. Alternative RNA processing in calcitonin gene expression generates mRNAs encoding different polypeptide products. Nature 1982; 298:240-4.
2. Rosenfeld MG, Mermod JJ, Amara SG, et al. Production of a novel neuropeptide encoded by the calcitonin gene via tissue-specific RNA processing. Nature 1982;304:129-35.
3. Morris HR, Panico M, Etienne T, Tippins J, Girgis SI, MacIntyre I. Isolation and characterization of human calcitonin gene-related peptide. Nature 1984;308:746-8.
4. Pettersson M, Ahren B, Bottcher G, Sundler F. Calcitonin gene-related peptide: occurrence in pancreatic islets in the mouse and the rat and inhibition of insulin secretion in the mouse. Endocrinology 1986;119:865-69.
5. Sternini C, Brecha N. Immunocytochemical identification of islet cells and nerve fibers containing calcitonin gene-related peptide-like immunoreactivity in the rat pancreas. Gastroenterology 1986; 90:1155-63.
6. Su HC, Bishop AE, Power RF, Hamada Y, Polak JM. Dual intrinsic and extrinsic origins of CGRP- and NPY-immunoreactive nerves of rat gut and pancreas. J Neurosci 1987;7:2674-87.
7. Sternini C, De Giorgio R, Anderson K, et al. Species differences in the immunoreactive patterns of calcitonin gene-related peptide in the pancreas. Cell Tissue Res 1992;269:447-58.
8. Fujimura M, Greeley GH Jr, Hancock MB, et al. Colocalization of calcitonin gene-related peptide and somatostatin in pancreatic islet cells and inhibition of insulin secretion by calcitonin gene-related peptide in the rat. Pancreas 1988;3:49-52.
9. Sternini C, Card JP. Ultrastructural characterization of calcitonin gene-related peptide-containing fibers and islet cells in the rat pancreas. Pancreas 1991;6:375-84.
10. Westermark P, Wernstedt C, Wilander E, Hayden DW, O'Brien TD, Johnson KH. Amyloid fibrils in human insulinoma and islets of Langerhans of the diabetic cat are derived from a neuropeptide-like protein also present in normal islet cells. Proc Natl Acad Sci USA 1987;84:3881-5.
11. Ahren B, Sundler F. Localization of calcitonin gene-related peptide and islet amyloid polypeptide in the rat and mouse pancreas. Cell Tissue Res 1992;269:315-22.
12. Pettersson M, Ahren B. Insulin and glucagon secretion in rats: effects of calcitonin gene-related peptide. Regul Pept 1988;23:37-50.
13. Ishizuka J, Greeley GH Jr, Cooper CW, Thompson JC. Effect of calcitonin gene-related peptide on glucose and gastric inhibitory polypeptide-stimulated insulin release from cultured newborn and adult rat islet cells. Regul Pept 1988;20:73-82.
14. Ishizuka J, Singh P, Greeley GH Jr, et al. A comparison of the insulinotropic and the insulin-inhibitory actions of gut peptide on newborn and adult rat islet cells. Pancreas 1988;3:77-82.
15. Kawano K, Hirashima T, Mori S, Saitoh Y, Kurosumi M, Natori T. Spontaneous long-term hyperglycemic rat with diabetic complications. Otsuka Long-Evans Tokushima Fatty (OLETF) strain. Diabetes 1992;41:1422-8.
16. Hsu S-M, Raine L, Fanger H. Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures. J Histochem Cytochem 1981;29:577-80.
17. Nishino T, Kodaira T, Shin S, et al. Glucagon radioimmunoassay with use of antiserum to glucagon C-terminal fragment. Clin Chem 1981;27:1690-7.
18. Ito S, Yamada Y, Iwanaga Y, Shibata A. Presence of somatostatin-28 like immunoreactivity in the human pancreas. Life Sci 1982; 30:1707-11.
19. Ito S, Isemura S, Saitoh E, Sanada K, Shibata A. The presence of prolin-rich peptide P-C like immunoreactivity in the human pancreatic B-cells. Nippon Naibunpi Gakkai Zasshi 1983;59:175-81.
20. Ahren B, Taborsky GJ Jr, Porte D Jr. Neuropeptidergic versus cholinergic and adrenergic regulation of islet hormone secretion. Diabetologia 1986;29:827-36.
21. Leighton B, Cooper GJS. Pancreatic amylin and calcitonin gene-related peptide cause resistance to insulin in skeletal muscle in vitro. Nature 1988;335:632-5.
22. Aponte G, Gross D, Yamada T. Capillary orientation of rat pancreatic D-cell processes: evidence for endocrine release of somatostatin. Am J Physiol 1985;249:G599-606.
23. Kato T, Katagiri T, Hirano A, et al. Calcitonin gene-related peptide immunoreactivity in spinal spheroids in motor neuron disease. Acta Neuropathol 1991;82:302-5.